# Vero Biotech Inc. — Form D

Vero Biotech Inc. of ATLANTA, GA, a company, filed a Form D exempt-offering notice with the SEC on 2017-09-29. The offering totals $35.1M, of which $29.9M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2017-09-29
- Form: D
- Accession: 0001359620-17-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $35.1M
- Amount sold: $29.9M
- Remaining: $5.2M
- Investors: 31
- Date of first sale: 2017-09-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-295706

## Issuer

- Name: Vero Biotech Inc.
- CIK: 0001359620
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: 387 TECHNOLOGY CIR. NW, ATLANTA, GA, 30313
- Phone: 678-862-7729

## Officers, directors & promoters (31)

_Showing 25 of 31 people._

| Name | Role | Location |
| --- | --- | --- |
| Todd Scott Brady | Director | Cocoa, FL |
| David H Fine, Ph.D. | Director | Cocoa, FL |
| Brent H Furse | Director | Cocoa, FL |
| T. Scott Johnson, M.D. | Director | Cocoa, FL |
| Theo Scott Melas-Kyriazi | Director | Cocoa, FL |
| Vinzenz Scott Ploerer | Director | Cocoa, FL |
| Dan Scott Salazar, Ph.D. | Director | Cocoa, FL |
| Paul Scott Antinori | Executive Officer | Concord, MA |
| David H Fine, Ph.D. | Executive Officer | Cocoa, FL |
| Brent H Furse | Executive Officer | Cocoa, FL |
| Anthony Scott Loumidis | Executive Officer | Cocoa, FL |
| Tod Scott Shultz | Executive Officer | Cocoa, FL |
| James O'Brien | Director | New York, NY |
| James O'Brien | Executive Officer | New York, NY |
| Daniel Salazar | Director | Clinton, MA |
| Todd Brady | Director | Atlanta, GA |
| Thiago V Tavares | Director | Atlanta, GA |
| Shasha V Zou | Executive Officer | Atlanta, GA |
| Eric V Bednarski | Director | Atlanta, GA |
| Brent V Furse | Director | Atlanta, GA |
| Brent V Furse | Executive Officer | Atlanta, GA |
| Roberto V Cohen | Executive Officer | Atlanta, GA |
| Steven Shulman | Director | New York, NY |
| Steven Shulman | Executive Officer | New York, NY |
| Theo Melas-Kyriazi | Director | Cambridge, MA |

## Other filings by this issuer (6)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-12-22](https://search.stillhousedata.com/formd/0001359620-21-000005) | D | $99.5M | $27.3M |
| [2013-10-18](https://search.stillhousedata.com/formd/0001359620-13-000004) | D/A | $17.0M | $14.7M |
| [2013-10-03](https://search.stillhousedata.com/formd/0001359620-13-000003) | D | $14.6M | $14.6M |
| [2011-12-29](https://search.stillhousedata.com/formd/0001359620-11-000002) | D | $10.5M | $8.0M |
| [2009-09-14](https://search.stillhousedata.com/formd/0001359620-09-000003) | D | $3.0M | $2.1M |
| [2009-09-14](https://search.stillhousedata.com/formd/0001359620-09-000004) | D | $3.5M | $2.1M |

## More

- [CIK 1359620 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1359620&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001359620-17-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.